Bourdon M, Peigné M, Maignien C, de Villardi de Montlaur D, Solignac C, Darné B, Languille S, Bendifallah S, Santulli Pietro
Department of Gynecology Obstetrics II and Reproductive Medicine (Professor Chapron), Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Universitaire Paris Centre (HUPC), Centre Hospitalier Universitaire (CHU) Cochin, Université de Paris Cité, Faculté de Santé, Paris, France.
Department 3I "Infection, Immunité Et Inflammation", Institut Cochin, INSERM U1016, Paris, France.
Reprod Sci. 2024 Jun;31(6):1431-1455. doi: 10.1007/s43032-023-01421-7. Epub 2024 Jan 2.
Endometriosis-related infertility remains a therapeutic challenge. A burning issue in this field of research is determining whether pre-assisted reproductive technology (ART) surgery may be of some benefit in terms of reproductive outcomes. This systematic review and meta-analysis aimed at comparing ongoing pregnancy rates (OPR) and/or live birth rates (LBR) in patients who underwent endometriosis surgery before ART (IVF/ICSI) in comparison with patients who underwent first-line ART (IVF/ICSI). Searches were conducted from January 1990 to June 2021 on PubMed, Embase, and Cochrane Library using the following search terms: endometriosis, surgery, reproductive outcomes, and IVF/ICSI. The primary outcomes were OPR or LBR. A total of 19 studies were included in the meta-analysis. No statistically significant differences in LBR [0.91[0.63, 1.30]; I = 66%; n = 11], OPR [1.28[0.66, 2.49]; I = 60%; n = 3], and early pregnancy loss rate [0.88[0.62, 1.25]; I = 0%; n = 7] per cycle were found when comparing patients who underwent endometriosis surgery before IVF/ICSI and those who did not. After the exclusion of the studies with high risks of bias, the LBR per cycle was significantly reduced in the case of surgical treatment before IVF/ICSI [0.53[0.33, 0.86]; I = 30%; n = 4]. These data urge the clinician to carefully weigh the pros and cons before referring infertile patients with endometriosis to surgery before IVF, highlighting the key role of multidisciplinary referral centers.
子宫内膜异位症相关的不孕症仍然是一个治疗难题。该研究领域的一个亟待解决的问题是,确定辅助生殖技术(ART)前的手术在生殖结局方面是否有益。本系统评价和荟萃分析旨在比较在ART(体外受精/卵胞浆内单精子注射)前接受子宫内膜异位症手术的患者与接受一线ART(体外受精/卵胞浆内单精子注射)的患者的持续妊娠率(OPR)和/或活产率(LBR)。使用以下检索词于1990年1月至2021年6月在PubMed、Embase和Cochrane图书馆进行检索:子宫内膜异位症、手术、生殖结局和体外受精/卵胞浆内单精子注射。主要结局为OPR或LBR。荟萃分析共纳入19项研究。比较体外受精/卵胞浆内单精子注射前接受子宫内膜异位症手术的患者和未接受手术的患者时,每个周期的LBR[0.91[0.63, 1.30];I=66%;n=11]、OPR[1.28[0.66, 2.49];I=60%;n=3]和早期流产率[0.88[0.62, 1.25];I=0%;n=7]均无统计学显著差异。排除具有高偏倚风险的研究后,体外受精/卵胞浆内单精子注射前手术治疗组的每个周期LBR显著降低[0.53[0.33, 0.86];I=30%;n=4]。这些数据促使临床医生在将子宫内膜异位症不孕患者转介至体外受精前手术时仔细权衡利弊,凸显了多学科转诊中心的关键作用。